Doses First Subject in Phase 1 Trial with HTL0033744, an EP4 Agonist for Inflammatory Bowel Disease (IBD

Oncology and Immunology A disturbed metabolite-GPCR axis is associated with microbial dysbiosis in IBD

stem cells to exacerbate colitis Published date May 21, 2024 Abstract "Inflammatory bowel disease (IBD However, the direct interactions between IBD microbial factors and ISCs are undescribed. Zhang , Dan Cao , Rongbin Zhou , Sheng Wang , Xinyang Song , Shu Zhu , Wen Pan Tags Enterococcus , IBD